Why do superior technologies fail?
The essay walks through why cleared devices sit unused, and what adoption actually requires: workflow fit, reimbursement, and a champion inside the room.
Read →Boards bring me in when the technology or the asset already exists but the company is not yet the organization it needs to become. Four decades, six industries operated from the inside, $95M+ raised across three continents.
SOFTWARE→MINING→CAPITAL→CYBERSECURITY→MEDTECH→AI
Bellevue, Washington · juan@juanvegarra.com

“Juan shares practical frameworks for identifying market shifts, communicating value, building enduring businesses, and leading through uncertainty… ideas here that are both insightful and immediately useful.”
Twenty-two prompts across two tools — and, with each one, a standard for judging what the AI hands back.
Stock Diligence. Eleven prompts that pressure-test a company before you buy it. The first treats your business and your portfolio as a single balance sheet, because if you own a company your largest position is not in your brokerage account.
Retirement. Eleven prompts that build the plan in the order the decisions actually arrive. The first values what you cannot sell — founder equity, a private stake, a stake with no market — because that is the number every other calculation runs on, and it is usually the one nobody checks.
No signup. No email. They are a gift.
Technology rarely fails on merit. It fails because the company around it stayed the size and shape it was when the technology was still an idea. Boards call me at exactly that moment — the asset is real, the market is real, and the organization is two years behind both.
Strengthen the enterprise first. Then accelerate growth.
Six industries, no incumbent credentials in any of them, the same operating system each time. This is the claim above, shown rather than asserted.
The essay walks through why cleared devices sit unused, and what adoption actually requires: workflow fit, reimbursement, and a champion inside the room.
Read →Trust is earned through augmentation, evidence, and the discipline to let the professional remain the author of the decision.
Read →The book's argument in one line: the outsider's real advantage is permission to reorder assumptions the incumbents can no longer see.
Read →The first commercial decision a MedTech company makes is buried in its 510(k) paperwork — years before anyone in the building calls it a commercial decision at all.
Read →A dataset is a snapshot that decays. A moat is a flywheel.
Read →Prove the motion, then pour the capital. In that order, always.
Read →Three clinical worlds, three definitions of better.
Read →The generalist is not a compromise. The generalist is an edge.
An Outsider’s Playbook is twenty short chapters on building enterprise value in industries I did not come from. Each one closes with an operating principle you can use on Monday.
Also in Spanish as El Manual del Outsider.
Everything here starts as a conversation on LinkedIn: an essay, an argument, a pattern someone pushes back on. This site is where those conversations get room to breathe. The best way to be part of it is to follow along and disagree with me in public, where everyone learns something.
And when a question needs more privacy than a comment thread, the inbox in the footer is open. It works in English or Spanish.
One essay most weeks on building companies, raising capital, and commercializing technology in markets that demand evidence.